Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.19
Delayed Data
As of Jul 19
 +0.03 / +0.33%
Today’s Change
6.90
Today|||52-Week Range
9.88
+7.23%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close9.16
Today’s open9.16
Day’s range9.07 - 9.21
Volume162,090
Average volume (3 months)359,598
Market cap$728.2M
Dividend yield--
Data as of 07/19/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+18.00%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book4.41

Competitors

 Today’s
change
Today’s
% change
KANGiKang Healthcare Gro...+0.10+0.81%
NTRANatera Inc-0.42-3.77%
ENZEnzo Biochem Inc+0.16+1.40%
NVTAInvitae Corp+0.10+1.06%
Data as of 07/19/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts